Literature DB >> 3718865

Methotrexate toxicity precipitated by azapropazone.

H M Daly, G L Scott, J Boyle, C J Roberts.   

Abstract

We report an episode of bone marrow hypoplasia following the administration of azapropazone to a patient stabilized on regular methotrexate for psoriasis. A pharmacokinetic interaction is postulated.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3718865     DOI： 10.1111/j.1365-2133.1986.tb04883.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


  5 in total

1.  Near fatal drug interactions with methotrexate given for psoriasis.

Authors:  H W Ng; A W Macfarlane; R M Graham; J L Verbov
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-26

Review 2.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

3.  Severe renal toxicity due to intermediate-dose methotrexate.

Authors:  A N Stark; G Jackson; P J Carey; S Arfeen; S J Proctor
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 4.  Slow-acting antirheumatic drugs. Drug interactions of clinical significance.

Authors:  R A Munro; R D Sturrock
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

5.  [Drug interactions in clinical practice. A pilot project for quality assurance in prescribing].

Authors:  U Geppert; W Beindl; T Hawranek; H Hintner
Journal:  Hautarzt       Date:  2002-12-20       Impact factor: 0.751
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.